Revolution in lung cancer new challenges for the surgical pathologist

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 1, 2011, Pages 110-116

  Cagle, Philip T ^a,b   Allen, Timothy C ^c   Dacie, Sanja ^d   Beth Beasley, Mary ^e   Borczuk, Alain C ^f   Chirieac, Lucian R ^g   Laucirica, Rodolfo ^h   Ro, Jae Y ^a,b   Kerr, Keith M ^i,j  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF TEXAS AT TYLER   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^j UNIVERSITY OF ABERDEEN   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; CLASSIFICATION; HUMAN; LUNG TUMOR; MOLECULARLY TARGETED THERAPY; PATHOLOGY; PERSONALIZED MEDICINE; PROFESSIONAL STANDARD;

ADENOCARCINOMA; HUMANS; INDIVIDUALIZED MEDICINE; LUNG NEOPLASMS; MOLECULAR TARGETED THERAPY; PATHOLOGY, SURGICAL; PROFESSIONAL ROLE; TUMOR MARKERS, BIOLOGICAL;

EID: 79251643266     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Jemal A, Siegel R, Ward E, Hao y, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2009;59(4):225-249.
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007,18(3): 581-592.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
4. Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J Thorac Oncol. 2008;3(8): 819-831.
5. Cagle PT, Jagirdar J, Popper H. Molecular pathology and genetics of lung cancer. In: Tomashefski J Jr, Cagle PT, Farver C, Fraire A, eds. Dail and Hammar's Pulmonary Pathology. Vol 2. 3rd ed. New York, NY: Springer; 2008:47-157.
6. Kerr KM. Pulmonary adenocarcinomas: classification and reporting. Histopathology. 2009,54(1):12-27.
7. Stinchcombe TE, Socinski MA. Current treatments for advanced stage nonsmall cell lung cancer. Proc Am Thorac Soc. 2009;6(2):233-241.
8. Selvaggi G, Scagliotti GV. Histologic subtype in NSCLC: does it matter? Oncology (Williston Park). 2009,23(13):133-1140.
9. Rossi A, Maione P, Bareschino MA, et al. The emerging role of histology in the choice of first-line treatment of advanced non-small cell lung cancer: implication in the clinical decision-making [published online ahead of print February 16, 2010]. Curr Med Chem. 2010/17(11):1030-1038.
10. Travis WD, Brambilla E, Noguchi M, et al. The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2009;4(9)(suppl 1) S86-S89.
11. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007; 297(9):953-961.
12. Bach PB. Is our natural-history model of lung cancer wrong? Lancet Oncol. 2008;9(7):693-697.
13. Chirieac LR, Flieder DB. High-resolution computed tomography screening for lung cancer: unexpected findings and new controversies regarding adenocarcinogenesis. Arch Pathol Lab Med. 2010;134(1):41-48.
14. Warner E, Jotkowitz A, Maimon N. Lung cancer screening-are we there yet? Eur J Intern Med. 2010;21(1):6-11.
15. Tanner NT, Silvestři GA. An up to date look at lung cancer screening [published ahead of print January 18, 2010]. Cell Adh Migr. 2010;4(1):96-99.
16. Travis WD, Colby TV, Corrin B, et al., eds. Histological Typing of Lung and Pleural Tumours. 3rd ed. Berlin, Germany: Springer-Verlag; 1999. World Health Organization International Histological Classification of Tumours.
17. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus, and Heart. 3rd ed. Lyon, France: IARC Press; 2004. World Health Organization Classification of Tumours; vol 10.
18. Dacic S. Minimally invasive adenocarcinomas of the lung. Adv Anal Pathol. 2009(3):166-171.
19. Chilosi M, Murer B. Mixed adenocarcinomas of the lung: place in new proposals in classification, mandatory for target therapy. Arch Pathol Lab Med. 2010;134(1):55-65.
20. Noguchi M. Stepwise progression of pulmonary adenocarcinoma- clinical and molecular implications. Cancer Metastasis Rev. 2010;29(1):15-21.
21. Okudela K, Woo T, Mitsui H, et al. Proposal of an improved histological sub-typing system for lung adenocarcinoma-significant prognostic values for stage I disease. Int J Clin Exp Pathol. 2010 March 25;3(4):348-366.
22. Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol. 2010;5(4):442-447.
23. Sica G, Yoshizawa A, Sima CS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol. 2010;34(8):1155-1162.
24. Cagle PT. Lung carcinoma staging problems. In: Dacic S, ed. Surgical Pathology Clinics: Current Concepts in Pulmonary Pathology. Philadelphia, PA: Elsevier; 2010:61-69.
25. Cagle PT, Kerr KM. Chapter 3: Adenocarcinoma. In: Cagle PT, Allen TC, Dacic S, Kerr KM, Beasley MB, eds. Advances in Surgical Pathology: Lung Cancer. New York, NY: Lippincott, Williams & Wilkins; 2010. In press.
26. Cagle PT, Kerr KM. Chapter 4: bronchioloalveolar carcinoma/ adenocarcinoma-in-situ. In: Cagle PT, Allen TC, Dacic S, Kerr KM, Beasley MB, eds. Advances in Surgical Pathology: Lung Cancer. New York, NY: Lippincott, Williams & Wilkins; 2010. In press.
27. Cagle PT, Kerr KM. Chapter 5: proposed revisions to the classification of adenocarcinoma. In: Cagle PT, Allen TC, Dacic S, Kerr KM, Beasley MB, eds. Advances in Surgical Pathology: Lung Cancer. New York, NY: Lippincott, Williams & Wilkins; 2010. In press.
28. Dacic S. Molecular targeted therapy of lung cancer. In: Cagle PT, Allen TC, Dacic S, Kerr KM, Beasley MB. Advances in Surgical Pathology: Lung Cancer. New York, NY: Lippincott, Williams & Wilkins; 2010. In press.
29. Liebow AA. Bronchiolo-alveolar carcinoma. Adv Intern Med. 1960;10: 329-358.
30. Cagle PT. Carcinoma of the lung. In: Churg AM, Myers JL, Tazelaar HD, Wright JL, eds. Pathology of the Lung. 3rd ed. New York, NY: Thieme Medical Publishers; 2005:413-479.
31. Jackman DM, Chirieac LR, Jänne PR. Bronchioloalveolar carcinoma: a review of the epidemiology, pathology, and treatment. Semin Respir Crit Care Med. 2005;26(3):342-352.
32. Christiani DC, Pao W, DeMartini JC, et al. BAC consensus conference, November 4-6, 2004: epidemiology, pathogenesis, and preclinical models. J Thorac Oncol. 2004;1(9)(suppl):S2-S7.
33. Travis WD, Garg K, Franklin WA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol. 2006; 1(9)(suppl):S13-S19.
34. Yousem SA, Beasley MB. Bronchioloalveolar carcinoma: a review of current concepts and evolving issues. Arch Pathol Lab Med. 2007,131(7):1027-1032.
35. Garfield DH, Cadranel J, West HL. Bronchioloalveolar carcinoma: the case for two diseases. Clin Lung Cancer. 2008;9(1 ):24-29.
36. Laga AC, Allen T, Ostrowski M, Cagle PT. Adenocarcinoma. In: Cagle PT, ed. The Color Atlas and Text of Pulmonary Pathology. 2nd ed. New York, NY: Lippincott Williams & Wilkins; 2008:31-35.
37. Flieder DB, Hammar SP. Common non-small cell carcinomas and their variants. In: Tomashefski J Jr, Cagle PT, Farver C, Fraire A., eds. Dail and Hammar's Pulmonary Pathology. Vol 2. 3rd ed. New York, NY: Springer; 2008: 216-307.
38. Jones KD. Malignant epithelial neoplasms. In: Cagle PT, Allen TC, Beasley MB, eds. Diagnostic Pulmonary Pathology. 2nd ed. New York, NY: Informa; 2008:611-626.
39. Kwon KY, Kerr KM, RoJY. Non-small cell carcinomas. In: Cagle PT, Allen TC, Kerr KM, eds. Transbronchial and Endobronchial Biopsies. New York, NY: Lippincott, Williams & Wilkins; 2009:7-19.
40. Miller RR, Nelems B, Evans KG Müller NL, Ostrow DN. Glandular neoplasia of the lung: a proposed analogy to colonic tumours. Cancer. 1988; 61(5):1009-1014.
41. Miller RR. Bronchioloalveolar cell adenomas. Am J Surg Pathol. 1990; 14(10):904-912.
42. Chapman AD, Kerr KM. The association between atypical adenomatous hyperplasia and primary lung cancer. Br J Cancer. 2000;83(5):632-636.
43. Mori M, Rao SK, Popper HH, Cagle PT, Fraire AE. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung. Mod Pathol. 2001;14(2):72-84.
44. Kerr KM. Pulmonary preinvasive neoplasia. ; Clin Pathol. 2001;54(4):257-271.
45. Ullmann R, Bongiovanni M, Halbwedl I, et al. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma? J Pathol. 2003;201 (3): 371-376.
46. Kerr KM, Fraire AE. Pre-invasive disease. In: Tomashefski JF Jr, Cagle PT, Farver CF, Fraire AE, eds. Dail and Hammar's Pulmonary Pathology. Vol 2. 3rd ed. New York, NY: Springer; 2008:158-215.
47. Kerr KM. Preneoplastic and preinvasive lesions. In: Cagle PT, Allen TC, Beasley MB, eds. Diagnostic Pulmonary Pathology. 2nd ed. New York, NY: Informa; 2008:519-537.
48. Noguchi M, Morikawa A, Kawasaki M. et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer. 1995;75(12):2844-2852.
49. Zell JA, Ou SH, Ziogas A, Anton-Culver H. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol. 2005;23(33):8396-8405.
50. Terasaki H, Niki T, Matsuno Y, et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol. 2003;27(7):937-951.
51. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol. 2004;28(2):198-206.
52. Minami Y, Matsuno Y, lijima T, et al. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer. 2005;48(3):339-348.
53. Okudera K, Kamata Y, Takanashi S, et al. Small adenocarcinoma of the lung: prognostic significance of central fibrosis chiefly because of its association with angiogenesis and lymphangiogenesis. Pathol Int. 2006;56(9):494-502.
54. Sakao Y, Miyamoto H, Sakuraba M, et al. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components. Ann Thorac Surg. 2007;83(1):209-214.
55. Weydert JA, Cohen MB. Small peripheral pulmonary adenocarcinoma: morphologic and molecular update. Adv Anat Pathol. 2007;14(2): 120-128.
56. Soh J, Toyooka S, lchihara S, et al. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung. J Thorac Oncol. 2008;3(4):340-347.